PDGFRB and Sarcoma: Association Evidence

Gene-Disorder Association · Article

Gene

PDGFRB

Platelet Derived Growth Factor Receptor Beta

Disorder

Sarcoma

First reported 2003

Supporting publications 1

Key publication · gene–disorder Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.Journal of experimental & clinical cancer research : CR · 2003

Key publication · disorder The sarcomas of the stomach: a review with reference to gross pathology and gastroscopic manifestations.The American journal of digestive diseases · 1950

Manually curated

Association Review

In brief

The association between PDGFRB (Platelet Derived Growth Factor Receptor Beta) and Sarcoma is reported, with clinical genetic testing available.

Sources 1

Clinical variants 0

Symptoms 0

Compounds 0

Trials 0

Publications 1

At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access

Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access

PDGFRB

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access

Sarcoma

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access

Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access

Provenance

References & sources

4 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access